A detailed history of Vontobel Holding Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 7,620 shares of PTCT stock, worth $573,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,620
Previous 7,536 1.11%
Holding current value
$573,786
Previous $368,000 26.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$43.3 - $62.88 $3,637 - $5,281
84 Added 1.11%
7,620 $467,000
Q2 2025

Jul 23, 2025

SELL
$36.19 - $52.13 $120,150 - $173,071
-3,320 Reduced 30.58%
7,536 $368,000
Q1 2025

Apr 25, 2025

SELL
$41.81 - $57.17 $28,263 - $38,646
-676 Reduced 5.86%
10,856 $553,000
Q4 2024

Jan 29, 2025

BUY
$34.99 - $52.07 $403,504 - $600,471
11,532 New
11,532 $520,000
Q3 2023

Jun 03, 2024

SELL
$22.41 - $41.99 $20,662 - $38,714
-922 Reduced 3.77%
23,513 $526,000
Q3 2023

Oct 10, 2023

SELL
$22.41 - $41.99 $20,662 - $38,714
-922 Reduced 3.77%
23,513 $526,000
Q2 2023

Jun 03, 2024

BUY
$40.4 - $59.1 $987,174 - $1.44 Million
24,435 New
24,435 $993,000
Q2 2023

Jul 24, 2023

BUY
$40.4 - $59.1 $987,174 - $1.44 Million
24,435 New
24,435 $993,000
Q3 2022

Nov 04, 2022

SELL
$41.85 - $53.85 $84,788 - $109,100
-2,026 Reduced 5.41%
35,425 $1.78 Million
Q2 2022

Jul 27, 2022

BUY
$25.6 - $45.23 $147,712 - $260,977
5,770 Added 18.21%
37,451 $1.51 Million
Q1 2022

May 13, 2022

SELL
$33.33 - $44.6 $45,928 - $61,458
-1,378 Reduced 4.17%
31,681 $1.18 Million
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $1.17 Million - $1.38 Million
33,059 New
33,059 $1.32 Million
Q2 2021

Aug 06, 2021

SELL
$37.95 - $49.37 $881,426 - $1.15 Million
-23,226 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$46.8 - $68.92 $5,850 - $8,615
125 Added 0.54%
23,226 $1.1 Million
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $1.11 Million - $1.56 Million
23,101 New
23,101 $1.48 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.